Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad, reducing their need for clinic visits. New guidance (PDF) from health ...

Xero's Melio acquisition creates a new strategy to penetrate the US market. Click here to see why XROLF stock is a Buy.

Washington could join more than a dozen states that have regulations on fast-growing and controversial license-plate-reading ...

No code automation platforms let you build workflows and connect apps without writing any code, making them accessible to ...